Hui Mao

Title: Innovations of Inventor Hui Mao

Introduction

Hui Mao is a prominent inventor based in Johns Creek, GA (US), known for his significant contributions to the field of biotechnology. With a total of six patents to his name, he has made remarkable advancements in the development of fusion proteins and nanoparticles aimed at cancer treatment.

Latest Patents

Hui Mao's latest patents include innovative fusion proteins that combine a toxin with a cancer marker. These nanoparticles are coated with fusion proteins that feature a domain binding to cancer markers such as urokinase plasminogen activator receptor (uPAR), insulin-like growth factor 1 receptor (IGF1R), EGFR, HER2, and other members of the ErbB family of receptors. The molecules that bind to these cancer markers include amino terminal fragments of uPA or variants capable of binding uPAR and/or IGF1 or variants capable of binding IGF1R. Additionally, the toxic polypeptide utilized in these inventions is a bacterial exotoxin, showcasing the innovative approach Hui Mao takes in addressing cancer treatment.

Career Highlights

Throughout his career, Hui Mao has worked with esteemed institutions such as Emory University and Children's Healthcare of Atlanta, Inc. His work has significantly impacted the field of cancer research and treatment, demonstrating his commitment to advancing medical science.

Collaborations

Hui Mao has collaborated with notable colleagues, including Lily Yang and Jing Huang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hui Mao's contributions to biotechnology, particularly in the development of targeted cancer therapies, highlight his role as a leading inventor in the field. His innovative patents and collaborations reflect a dedication to improving healthcare outcomes through scientific advancements.